Skip to main content
SpringerLink
Log in

Diabetes and Cardiovascular Disease

  • Chapter
  • First Online:
Diabetes and Hypertension

Part of the book series: Contemporary Diabetes ((CDI))

  • 2164 Accesses

Abstract

Patients with diabetes have a risk of death that is two to six times that among persons without diabetes; the age-adjusted prevalence of coronary heart disease is twice as high among those with type 2 diabetes as among those without diabetes. The cardiovascular disease events associated with diabetes and the high incidence of other macrovascular complications, such as strokes, amputations, and myocardial infarction, are a major cause of morbidity and mortality, and an enormous economic burden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 209.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. J Am Med Assoc. 1979;241:2035–8.

    Article  CAS  Google Scholar 

  2. Sowers JR, Whaley-Connell A, Hayden MR. The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med. 2011;1:5–12.

    Article  PubMed  Google Scholar 

  3. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic and clinical implications for diabetes and aging. Lab Invest. 1994;70:138–51.

    PubMed  CAS  Google Scholar 

  4. Bierhaus A, Hofmann MA, Ziegler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res. 1998;37: 586–600.

    Article  PubMed  CAS  Google Scholar 

  5. Koya D, King GL. Protein kinase C activation and the development of diabetes complications. Diabetes. 1998;47:859–66.

    Article  PubMed  CAS  Google Scholar 

  6. Vlassara H, Fuh H, Donnelly T, et al. Advanced glycation end products promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med. 1995;1:447–56.

    PubMed  CAS  Google Scholar 

  7. Egan BM, Lu G, Green EL. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostaglandins Leukot Essent Fatty Acids. 1999;60:411–1406.

    Article  PubMed  CAS  Google Scholar 

  8. Toft I, Bonna KH, Ingebresten OC, et al. Fibrinolytic function after dietary supplementation with omega 3 polyunsaturated fatty acids. Arterioscler Thromb Vasc Biol. 1997;17:814–9.

    Article  PubMed  CAS  Google Scholar 

  9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). J Am Med Assoc. 2001;285(19):2486–97. NIH Publication No. 01–3670, May 2001.

    Article  Google Scholar 

  10. Figler RA, Wang Q, Srinivasan S, et al. Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes. 2011;60(2):669–79.

    Article  PubMed  CAS  Google Scholar 

  11. Yamauchi T, Kamon J, Waki H, et al. Fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–6.

    Article  PubMed  CAS  Google Scholar 

  12. Lau DC, Dhillon B, Yan H, et al. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol. 2005;288:H2031–41.

    Article  PubMed  CAS  Google Scholar 

  13. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocytes-derived plasma protein adiponectin. Circulation. 1999;100:2473–6.

    Article  PubMed  CAS  Google Scholar 

  14. O’Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998;73:969–76.

    Article  PubMed  Google Scholar 

  15. Schimdt AM, Hori O, Brett J, et al. Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesion. Arterioscler Thromb. 1994;14:1521–8.

    Article  Google Scholar 

  16. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–26.

    Article  PubMed  CAS  Google Scholar 

  17. Szalai AJ, Van Ginkel FW, Wang Y, et al. Complement-dependent acute phase expression of C-reactive protein and serum amyloid P-component. J Immunol. 2000;165:1030–5.

    PubMed  CAS  Google Scholar 

  18. Schneider DJ, Sobel BE. Diabetes and thrombosis. In: Johnstone MT, Veves A, editors. Diabetes and cardiovascular disease. Totowa, NJ: Humana Press; 2001. p. 107–28.

    Google Scholar 

  19. Cardillo C, Nambi SS, Kilcoyne CM, et al. Insulin stimulates both endothelium and nitric oxide activity in the human forearm. Circulation. 1999;100:820–5.

    Article  PubMed  CAS  Google Scholar 

  20. Cooper SA, Whaley-Connell A, Habibi J, et al. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol. 2007;293:H2009–23.

    Article  PubMed  CAS  Google Scholar 

  21. Ren J, Pulakat L, Whaley-Connell A, et al. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010;88:993–1001.

    Article  PubMed  CAS  Google Scholar 

  22. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384–7.

    Article  PubMed  CAS  Google Scholar 

  23. Whaley-Connell A, Pulakat L, DeMarco VG, et al. Overnutrition and the cardiorenal syndrome: use of a rodent model to examine mechanisms. Cardiorenal Med. 2011;1:23–30.

    Article  PubMed  Google Scholar 

  24. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853.

    Google Scholar 

  25. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N EnglJMed. 1993;329:977–86.

    Article  Google Scholar 

  26. Gaede P, Vedel P, Larsren N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–90.

    Article  PubMed  Google Scholar 

  27. Del Prato S. Megatrials in type 2 Diabetes. From excitement to frustration? Diabetologia. 2009;52:1219–26.

    Article  PubMed  CAS  Google Scholar 

  28. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in ­veterans with type 2 diabetes. N Engl J Med. 2009;369:129–40.

    Article  Google Scholar 

  29. Heller SR, ADVANCE Collaborative Group. A summary of the ADVANCE Trial. Diabetes Care. 2009;32 Suppl 2:S357–62.

    Article  PubMed  Google Scholar 

  30. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  Google Scholar 

  31. Dale AC, Vatten LJ, Nilsen TI, et al. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. Br Med J. 2008;337:99–102.

    Article  Google Scholar 

  32. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.

    Article  Google Scholar 

  33. Holman RR, Paul SK, Bethel MA, et al. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.

    Article  PubMed  CAS  Google Scholar 

  34. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:580–91.

    Article  Google Scholar 

  35. Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomized controlled trials. Lancet. 2009;373:1765–72.

    Article  PubMed  CAS  Google Scholar 

  36. American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33:S11–48.

    Article  Google Scholar 

Download references

Acknowledgement

This work is supported by NIH R01-HL073101 and R01-HL107910 (JRS) and VA Merit Award (JRS).

Author information

Authors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO, USA

    Mariana Garcia-Touza & James R. Sowers M.D.

  2. Harry S. Truman Memorial Veterans’ Hospital, Columbia, MO, USA

    James R. Sowers M.D.

Authors
  1. Mariana Garcia-Touza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James R. Sowers M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James R. Sowers M.D. .

Editor information

Editors and Affiliations

  1. County Hospital, Division of Endocrinology,, SUNY-Downstate and Kings, 450 Clarkson Ave., Brooklyn, 11203, New York, USA

    Samy I. McFarlane

  2. ASH Comprehensive Hypertension Center, Department of Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC1027, Chicago, 60637, Illinois, USA

    George L. Bakris

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Garcia-Touza, M., Sowers, J.R. (2012). Diabetes and Cardiovascular Disease. In: McFarlane, S., Bakris, G. (eds) Diabetes and Hypertension. Contemporary Diabetes. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-357-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-357-2_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-356-5

  • Online ISBN: 978-1-60327-357-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation